Ocugen, Inc.
OCGN
$2.58
$0.2510.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.41M | 5.37M | 4.75M | 4.52M | 4.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.41M | 5.37M | 4.75M | 4.52M | 4.06M |
| Cost of Revenue | 31.01M | 28.63M | 25.59M | 26.09M | 25.75M |
| Gross Profit | -26.59M | -23.26M | -20.83M | -21.56M | -21.69M |
| SG&A Expenses | 27.58M | 27.76M | 25.81M | 26.74M | 26.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 842.00K | 1.17M | -154.00K | -154.00K | -154.00K |
| Total Operating Expenses | 68.17M | 66.30M | 59.99M | 61.41M | 58.66M |
| Operating Income | -63.76M | -60.93M | -55.23M | -56.89M | -54.60M |
| Income Before Tax | -67.85M | -64.02M | -56.94M | -57.48M | -54.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.85 | -64.02 | -56.94 | -57.48 | -54.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.85M | -64.02M | -56.94M | -57.48M | -54.05M |
| EBIT | -63.76M | -60.93M | -55.23M | -56.89M | -54.60M |
| EBITDA | -60.37M | -57.54M | -52.19M | -54.19M | -52.64M |
| EPS Basic | -0.23 | -0.22 | -0.20 | -0.21 | -0.20 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| EPS Diluted | -0.23 | -0.22 | -0.20 | -0.21 | -0.20 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 1.20B | 1.18B | 1.15B | 1.12B | 1.08B |
| Average Diluted Shares Outstanding | 1.20B | 1.18B | 1.15B | 1.12B | 1.08B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |